Valeant CEO says drug price increases will be modest in 2016

Valeant Pharmaceuticals is planning for minimal price increases on its products in 2016 in the wake of two U.S. investigations into its drug pricing practices.

from CBC | Health News http://ift.tt/1LkkzOW